Evolent Health Stock (NYSE:EVH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$3.06

52W Range

$2.50 - $12.06

50D Avg

$3.35

200D Avg

$6.73

Market Cap

$333.80M

Avg Vol (3M)

$3.13M

Beta

0.23

Div Yield

-

EVH Company Profile


Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

4,500

IPO Date

Jun 05, 2015

Website

EVH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Reportable Segment$1.88B--
Evolent Health Services Segment-$2.55B$1.96B

Fiscal year ends in Dec 25 | Currency in USD

EVH Financial Summary


Dec 25Dec 24Dec 23
Revenue$1.88B$2.55B$1.96B
Operating Income$-2.29B$-40.48M$-71.21M
Net Income$-579.40M$-61.62M$-113.04M
EBITDA$-361.31M$84.85M$-24.79M
Basic EPS$-5.07$-0.81$-1.28
Diluted EPS$-5.07$-0.81$-1.28

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 25, 26 | 5:00 PM
Q3 25Nov 07, 25 | 5:00 PM
Q2 25Aug 08, 25 | 5:00 PM

Peer Comparison


TickerCompany
PSNLPersonalis, Inc.
AMNAMN Healthcare Services, Inc.
NUTXNutex Health, Inc.
MGTXMeiraGTx Holdings plc
KURAKura Oncology, Inc.
MYGNMyriad Genetics, Inc.
AVBPArriVent BioPharma, Inc. Common Stock
HSTMHealthStream, Inc.
REPLReplimune Group, Inc.
BFLYButterfly Network, Inc.